Adult vaccinations: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
==Recommendations== | ==Recommendations== | ||
=== Recommended schedule of vaccination for adults aged 19 and older, by '''age group''', in the United States: === | |||
{| class="wikitable" | |||
! rowspan="2" |Vaccine | |||
! colspan="5" |Age in Years | |||
|- | |||
|19-21 | |||
|22-26 | |||
|27-59 | |||
|60-64 | |||
|>65 | |||
|- | |||
|'''Influenza''' | |||
| colspan="5" |1 dose annualy | |||
|- | |||
|'''Td/Tdap''' | |||
| colspan="5" |Substitute Tdap for Td once, then give Td booster evry 10 years | |||
|- | |||
|'''MMR''' | |||
| colspan="3" |1 or 2 doses depending on indication | |||
| | |||
| | |||
|- | |||
|'''VAR''' | |||
| colspan="5" |2 doses | |||
|- | |||
|'''HZV''' | |||
| | |||
| | |||
| | |||
| colspan="2" |1 dose | |||
|- | |||
|'''HPV-Female''' | |||
| colspan="2" |3 doses | |||
| | |||
| | |||
| | |||
|- | |||
|'''HPV-Male''' | |||
|3 doses | |||
| '''3 doses''' | |||
| | |||
| | |||
| | |||
|- | |||
|'''PCV13''' | |||
| colspan="4" | '''1 dose''' | |||
|1 dose | |||
|- | |||
|PPSV23 | |||
| colspan="4" | '''1 or 2 doses depending on indication''' | |||
|1 dose | |||
|- | |||
|HepA | |||
| colspan="5" | '''2 or 3 doses depending on vaccine''' | |||
|- | |||
|HepB | |||
| colspan="5" | '''3 doses''' | |||
|- | |||
|MenACWY or MPSV4 | |||
| colspan="5" | '''1 or 3 doses depending on indication''' | |||
|- | |||
|MenB | |||
| colspan="5" | '''2 or 3 doses depending on vaccine''' | |||
|- | |||
|Hib | |||
| colspan="5" | '''1 or 3 doses depending on indication''' | |||
|} | |||
=== Recommended schedule of vaccination for adults aged 19 and older, by '''medical condition and other indications''', in the United States: === | |||
{| class="wikitable" | |||
! rowspan="2" |Vaccine | |||
! rowspan="2" |Pregnancy | |||
! rowspan="2" |Immunocompromised | |||
(except HIV) | |||
! colspan="2" |HIV infection | |||
CD4+ count (cells/uL) | |||
! rowspan="2" |Asplenia, persistent | |||
complement deficiencies | |||
! rowspan="2" |Kidney failure, | |||
End stage renal disease | |||
on hemodialysis | |||
! rowspan="2" |Heart of Lung disease, | |||
chronic alcoholism | |||
! rowspan="2" |Chronic liver | |||
disease | |||
! rowspan="2" |Diabetes | |||
! rowspan="2" |Healthcare | |||
Personnel | |||
! rowspan="2" |Men who have | |||
sex with men | |||
|- | |||
|'''<200''' | |||
|'''>200''' | |||
|- | |||
!Influenza | |||
! colspan="11" |1 dose annualy | |||
|- | |||
!Td/Tdap | |||
!1 dose Tdap each pregnancy | |||
! colspan="10" |Substitute Tdap for Td once, then Td booster every 10 years | |||
|- | |||
!MMR | |||
! colspan="3" |Contraindicated | |||
! colspan="8" |1 or 2 doses depending on indication | |||
|- | |||
!VAR | |||
! colspan="3" |Contraindicated | |||
! colspan="8" |2 doses | |||
|- | |||
!HZV | |||
! colspan="3" |Contraindicated | |||
! | |||
! colspan="7" |1 dose | |||
|- | |||
!HPV-Female | |||
! | |||
! colspan="9" |3 doses through age 26 years | |||
! | |||
|- | |||
!HPV-Male | |||
! | |||
! colspan="3" |3 doses through age 26 years | |||
! colspan="6" |3 doses through age 21 years | |||
!3 doses through age 26 years | |||
|- | |||
!PCV13 | |||
! | |||
! colspan="5" |1 dose | |||
! colspan="5" |1 dose | |||
|- | |||
!PPSV23 | |||
!1 to 3 doses depending on indication | |||
! colspan="8" |1 to 3 doses depending on indication | |||
! colspan="2" |1 to 3 doses depending on indication | |||
|- | |||
!HepA | |||
! colspan="7" |2 or 3 doses depending on vaccine | |||
!2 or 3 doses depending on vaccine | |||
! colspan="2" |2 or 3 doses depending on vaccine | |||
!2 or 3 doses depending on vaccine | |||
|- | |||
!HepB | |||
! colspan="2" |3 doses | |||
! colspan="2" |3 doses | |||
!3 doses | |||
!3 doses | |||
!3 doses | |||
! colspan="4" |3 doses | |||
|- | |||
!MenACWY or MPSV4 | |||
! colspan="2" |1 or more doses depending on indication | |||
! colspan="3" |1 or more doses depending on indication | |||
! colspan="6" |1 or more doses depending on indication | |||
|- | |||
!MenB | |||
! | |||
! colspan="3" |2-3 doses depending on vaccine | |||
!2-3 doses depending on vaccine | |||
! colspan="6" |2-3 doses depending on vaccine | |||
|- | |||
!Hib | |||
! | |||
!3 doses post-HSCT | |||
recipients only | |||
! colspan="2" |1 dose | |||
!1 dose | |||
! colspan="6" |1 dose | |||
|} | |||
== General Information and Special Populations: == | |||
== Contraindications and Precautions for Adult Vaccinations: == | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 21:21, 6 April 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Overview
Recommendations
Recommended schedule of vaccination for adults aged 19 and older, by age group, in the United States:
Vaccine | Age in Years | ||||
---|---|---|---|---|---|
19-21 | 22-26 | 27-59 | 60-64 | >65 | |
Influenza | 1 dose annualy | ||||
Td/Tdap | Substitute Tdap for Td once, then give Td booster evry 10 years | ||||
MMR | 1 or 2 doses depending on indication | ||||
VAR | 2 doses | ||||
HZV | 1 dose | ||||
HPV-Female | 3 doses | ||||
HPV-Male | 3 doses | 3 doses | |||
PCV13 | 1 dose | 1 dose | |||
PPSV23 | 1 or 2 doses depending on indication | 1 dose | |||
HepA | 2 or 3 doses depending on vaccine | ||||
HepB | 3 doses | ||||
MenACWY or MPSV4 | 1 or 3 doses depending on indication | ||||
MenB | 2 or 3 doses depending on vaccine | ||||
Hib | 1 or 3 doses depending on indication |
Recommended schedule of vaccination for adults aged 19 and older, by medical condition and other indications, in the United States:
Vaccine | Pregnancy | Immunocompromised
(except HIV) |
HIV infection
CD4+ count (cells/uL) |
Asplenia, persistent
complement deficiencies |
Kidney failure,
End stage renal disease on hemodialysis |
Heart of Lung disease,
chronic alcoholism |
Chronic liver
disease |
Diabetes | Healthcare
Personnel |
Men who have
sex with men | |
---|---|---|---|---|---|---|---|---|---|---|---|
<200 | >200 | ||||||||||
Influenza | 1 dose annualy | ||||||||||
Td/Tdap | 1 dose Tdap each pregnancy | Substitute Tdap for Td once, then Td booster every 10 years | |||||||||
MMR | Contraindicated | 1 or 2 doses depending on indication | |||||||||
VAR | Contraindicated | 2 doses | |||||||||
HZV | Contraindicated | 1 dose | |||||||||
HPV-Female | 3 doses through age 26 years | ||||||||||
HPV-Male | 3 doses through age 26 years | 3 doses through age 21 years | 3 doses through age 26 years | ||||||||
PCV13 | 1 dose | 1 dose | |||||||||
PPSV23 | 1 to 3 doses depending on indication | 1 to 3 doses depending on indication | 1 to 3 doses depending on indication | ||||||||
HepA | 2 or 3 doses depending on vaccine | 2 or 3 doses depending on vaccine | 2 or 3 doses depending on vaccine | 2 or 3 doses depending on vaccine | |||||||
HepB | 3 doses | 3 doses | 3 doses | 3 doses | 3 doses | 3 doses | |||||
MenACWY or MPSV4 | 1 or more doses depending on indication | 1 or more doses depending on indication | 1 or more doses depending on indication | ||||||||
MenB | 2-3 doses depending on vaccine | 2-3 doses depending on vaccine | 2-3 doses depending on vaccine | ||||||||
Hib | 3 doses post-HSCT
recipients only |
1 dose | 1 dose | 1 dose |